EGO Stock Analysis: Eldorado Gold | NYSE
Gold | NYSE, USA | Market Cap: 11.924m USD | 12M Return: 89.7% | CA2849025093 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 111M
EPS Trend: 96.7%
Qual. Beats: 0
Rev. Trend: 99.5%
Qual. Beats: 0
Warnings
Tailwinds
Seasonality 11.6 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Eldorado Gold Corporation is a Canadian mining company headquartered in Vancouver that engages in the exploration, development, and sale of mineral products, primarily gold, along with by-product production of silver, lead, and zinc. The company operates across three core jurisdictions-Turkey, Canada, and Greece-holding 100% interests in the Kisladag and Efemçukuru mines in Turkey, the Lamaque complex in Quebec, and multiple Greek operations including Olympias, Stratoni, Skouries, Perama Hill, and Sapes. The company was originally incorporated in 1996 under its former name Eldorado Corporation Ltd. before adopting its current name later that year, and has been publicly traded on the NYSE since 2003.
As a mid-cap Materials sector issuer within the GICS Gold sub-industry, Eldorados financial performance is closely linked to global gold prices, reserve quality, and production costs, with revenue typically denominated in U.S. dollars while operating costs are spread across the Canadian dollar, Turkish lira, and euro. The companys diversified geographic footprint across three countries is a common strategy among multi-asset gold producers aimed at reducing country-specific regulatory and operational risk.
- Gold price strength lifts margins and free cash flow
- Skouries Greece project commissioning drives production growth
- Turkey lira weakness and political risk pressures operating costs
| Net Income: 604.7m TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.06 > 0.02 and ΔFCF/TA -6.18 > 1.0 |
| NWC/Revenue: 13.89% < 20% (prev 67.51%; Δ -53.62% < -1%) |
| CFO/TA 0.06 > 3% & CFO 658.2m > Net Income 604.7m |
| Net Debt (1.22b) to EBITDA (1.05b): 1.16 < 3 |
| Current Ratio: 1.31 > 1.5 & < 3 |
| Outstanding Shares: last quarter (254.0m) vs 12m ago 22.72% < -2% |
| Gross Margin: 48.68% > 18% (prev 51.95%; Δ -3.27% > 0.5%) |
| Asset Turnover: 24.44% > 50% (prev 24.92%; Δ -0.48% > 0%) |
| Interest Coverage Ratio: 28.13 > 6 (EBIT TTM 806.0m / Interest Expense TTM 28.7m) |
| A: 0.03 (Total Current Assets 1.18b - Total Current Liabilities 896.9m) / Total Assets 10.2b |
| B: -0.12 (Retained Earnings -1.28b / Total Assets 10.2b) |
| C: 0.10 (EBIT TTM 806.0m / Avg Total Assets 8.28b) |
| D: 2.03 (Book Value of Equity 6.85b / Total Liabilities 3.38b) |
| Altman-Z'' = 2.55 = A |
| DSRI: 1.04 (Receivables 207.5m/156.0m, Revenue 2.02b/1.57b) |
| GMI: 1.07 (GM 51.95% / 48.68%) |
| AQI: 1.59 (AQ_t 0.08 / AQ_t-1 0.05) |
| SGI: 1.29 (Revenue 2.02b / 1.57b) |
| TATA: -0.01 (NI 604.7m - CFO 658.2m) / TA 10.2b) |
| Beneish M = -2.38 (Cap -4..+1) = BBB |
As of August 30, 2026, the stock is trading at USD 45.48 with a total of 3,032,933 shares traded. Over the past week, the price has changed by -0.52%, over one month by +41.07%, over three months by +38.46% and over the past year by +89.69%.
Current recommended Stop Loss: 40.30 (which is 11.4% or 2.6 ATR below the current price).
Eldorado Gold has received a consensus analysts rating of 3.44. Therefore, it is recommended to hold EGO.
- StrongBuy: 1
- Buy: 3
- Hold: 4
- Sell: 1
- StrongSell: 0
| Analysts Target Price | 40.6 | -10.7% |
P/E Trailing = 14.8442
P/E Forward = 14.3472
P/S = 5.8689
P/B = 1.7378
P/EG = 5.958
Revenue TTM = 2.02b USD
EBIT TTM = 806.0m USD
EBITDA TTM = 1.05b USD
Long Term Debt = 1.52b USD (from longTermDebt, last quarter)
Short Term Debt = 236.8m USD (from shortTermDebt, last quarter)
Debt = 1.77b USD (from shortLongTermDebtTotal, last quarter) + Leases 13.2m
Net Debt = 1.22b USD (calculated: Debt 1.77b - CCE 553.9m)
Enterprise Value = 13.1b USD (11.9b + Debt 1.77b - CCE 553.9m)
Interest Coverage Ratio = 28.13 (Ebit TTM 806.0m / Interest Expense TTM 28.7m)
EV/FCF = -21.05x (Enterprise Value 13.1b / FCF TTM -624.4m)
FCF Yield = -4.75% (FCF TTM -624.4m / Enterprise Value 13.1b)
FCF Margin = -30.86% (FCF TTM -624.4m / Revenue TTM 2.02b)
Net Margin = 29.89% (Net Income TTM 604.7m / Revenue TTM 2.02b)
Gross Margin = 48.68% ((Revenue TTM 2.02b - Cost of Revenue TTM 1.04b) / Revenue TTM)
Gross Margin QoQ = 46.25% (prev 54.51%)
Tobins Q-Ratio = 1.28 (Enterprise Value 13.1b / Total Assets 10.2b)
Interest Expense / Debt = 1.61% (Interest Expense 28.7m / Debt 1.77b)
Taxrate = 23.05% (184.4m / 800.1m)
NOPAT = 620.3m (EBIT 806.0m * (1 - 23.05%))
Current Ratio = 1.31 (Total Current Assets 1.18b / Total Current Liabilities 896.9m)
Debt / Equity = 0.26 (Debt 1.77b / totalStockholderEquity, last quarter 6.85b)
Debt / EBITDA = 1.16 (Net Debt 1.22b / EBITDA 1.05b)
Debt / FCF = -1.95 (negative FCF - burning cash) (Net Debt 1.22b / FCF TTM -624.4m)
Total Stockholder Equity = 4.89b (last 4 quarters mean from totalStockholderEquity)
RoA = 7.30% (Net Income 604.7m / Total Assets 10.2b)
RoE = 12.38% (Net Income TTM 604.7m / Total Stockholder Equity 4.89b)
RoCE = 12.59% (EBIT 806.0m / Capital Employed (Equity 4.89b + L.T.Debt 1.52b))
RoIC = 6.54% (NOPAT 620.3m / Invested Capital 9.48b)
WACC = 6.94% (E(11.9b)/V(13.7b) * Re(7.79%) + D(1.77b)/V(13.7b) * Rd(1.61%) * (1-Tc(0.23)))
Discount Rate = 7.79% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 44.80 | Cagr: 10.24%
[DCF] Fair Price = unknown (Cash Flow -624.4m)
EPS Correlation: 96.66 | EPS CAGR: 74.30% | SUE: 0.16 | # QB: 0
Revenue Correlation: 99.54 | Revenue CAGR: 34.92% | SUE: -0.57 | # QB: 0
EPS current Quarter (2026-09-30): EPS=0.95 | Chg30d=-14.40% | Revisions=-50% | Analysts=6
EPS current Year (2026-12-31): EPS=3.42 | Chg30d=-14.15% | Revisions=-75% | GrowthEPS=+95.3% | GrowthRev=+48.9%
EPS next Year (2027-12-31): EPS=5.34 | Chg30d=-6.32% | Revisions=-75% | GrowthEPS=+56.3% | GrowthRev=+56.2%
[Analyst] Revisions Ratio: -88% (up=0, down=21)